White Paper

Breaking the GLP-1 cost cycle: Transforming access, cutting costs, and shaping the future of obesity care

Sponsor Content from
Thank you for your interest. You can now access the asset below.
{download_button}


Welcome back.
You have registered as {email}. .

{download_button}

Download now

Dive deeper into the obesity crisis, and discover revolutionary solutions that can enhance health outcomes and cost savings, including for those on GLP-1s or other anti-obesity medications.

Obesity is a complex, multifactorial disease that requires comprehensive medical attention and innovative treatment strategies. To meet diverse employer needs, this white paper unveils two tailored solutions, which can be supported either through an organization's current pharmacy benefit manager (PBM) or through a full carve-out for GLP-1 weight loss medications. Both enable affordable access to GLP-1 medications. This can significantly boost your ROI and broaden access to GLP-1s now, regardless of your organization's current coverage policies for obesity medications.

Download now to learn more.